08:47 AM EST - Satellos Bioscience Inc. : Today announced interim clinical and biomarker data for SAT-3247 at the Muscular Dystrophy Association Clinical & Scientific Conference in Orlando, Florida. Satellos Bioscience Inc.
shares T.MSCL are trading unchanged at $15.77.
